The use of prescription medication in 239 patients with multiple functional somatic syndromes

Wessely, 1999, Functional somatic syndromes: one or many?, Lancet, 354, 936, 10.1016/S0140-6736(98)08320-2 Henningsen, 2007, Management of functional somatic syndromes, Lancet, 369, 946, 10.1016/S0140-6736(07)60159-7 Creed, 2013, Multiple somatic symptoms predict impaired health status in functional somatic syndromes, Int J Behav Med, 20, 194, 10.1007/s12529-012-9257-y Rask, 2015, Leave and work disability in primary care patients with recent-onset multiple medically unexplained symptoms and persistent somatoform disorders: a 10-year follow-up of the FIP study, Gen Hosp Psychiatry, 37, 53, 10.1016/j.genhosppsych.2014.10.007 Fink, 2007, Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients, Psychosom Med, 69, 30, 10.1097/PSY.0b013e31802e46eb Hauser, 2009, Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials, Arthritis Rheum, 61, 216, 10.1002/art.24276 Agger, 2017, Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study, Lancet Psychiatry, 4, 378, 10.1016/S2215-0366(17)30126-8 Hauser, 2009, Fibromyalgia syndrome: classification, diagnosis, and treatment, Dtsch Arztebl Int, 106, 383 Arnold, 2017, Challenges of implementing fibromyalgia treatment guidelines in current clinical practice, Postgrad Med, 10.1080/00325481.2017.1336417 Thieme, 2017, Evidenced-based guidelines on the treatment of fibromyalgia patients: are they consistent and if not, why not? Have effective psychological treatments been overlooked?, J Pain, 18, 747, 10.1016/j.jpain.2016.12.006 Ngian, 2011, The use of opioids in fibromyalgia, Int J Rheum Dis, 14, 6, 10.1111/j.1756-185X.2010.01567.x Hauser, 2014, Review of pharmacological therapies in fibromyalgia syndrome, Arthritis Res Ther, 16, 201, 10.1186/ar4441 Okifuji, 2016, Management of fibromyalgia syndrome in 2016, Pain Manag, 6, 383, 10.2217/pmt-2016-0006 Chey, 2015, Irritable bowel syndrome: a clinical review, JAMA, 313, 949, 10.1001/jama.2015.0954 Robinson, 2012, Burden of illness and treatment patterns for patients with fibromyalgia, Pain Med, 13, 1366, 10.1111/j.1526-4637.2012.01475.x Faresjo, 2008, Self-reported use of pharmaceuticals among patients with irritable bowel syndrome in primary care, J Manag Care Pharm, 14, 870, 10.18553/jmcp.2008.14.9.870 Boneva, 2009, Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in Georgia, Health Qual Life Outcomes, 7, 10.1186/1477-7525-7-67 Sanchez, 2011, Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia, Curr Med Res Opin, 27, 663, 10.1185/03007995.2010.550605 Liu, 2016, Associated with ACR-recommended medications in the management of Fibromyalgia in the United States, J Manag Care Spec Pharm, 22, 263 McNett, 2011, Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States, Curr Med Res Opin, 27, 673, 10.1185/03007995.2011.553214 Schroder, 2011, Functional somatic syndromes and somatoform disorders in special psychosomatic units: organizational aspects and evidence-based treatment, Psychiatr Clin North Am, 34, 673, 10.1016/j.psc.2011.05.008 Fink, 2010, One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders, J Psychosom Res, 68, 415, 10.1016/j.jpsychores.2010.02.004 Kildemoes, 2011, The Danish National Prescription Registry, Scand J Public Health, 39, 38, 10.1177/1403494810394717 Schroder, 2012, Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial, Br J Psychiatry, 200, 499, 10.1192/bjp.bp.111.098681 Fjorback, 2013, Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up, J Psychosom Res, 74, 31, 10.1016/j.jpsychores.2012.09.006 World Health Organization, 1998 Ware, 2005 Petersen, 2018, Physical comorbidity in patients with multiple functional somatic syndromes. A register-based case-control study, J Psychosom Res, 104, 22, 10.1016/j.jpsychores.2017.11.005 Fink, 2004, A new, empirically established hypochondriasis diagnosis, Am J Psychiatry, 161, 1680, 10.1176/appi.ajp.161.9.1680 olde Hartman, 2004, Chronic functional somatic symptoms: a single syndrome?, Br J Gen Pract, 54, 922 Walitt, 2015, Selective serotonin reuptake inhibitors for fibromyalgia syndrome, Cochrane Database Syst Rev, 6, CD011735 Xie, 2015, Efficacy and safety of antidepressants for the treatment of irritable bowel syndrome: a meta-analysis, PLoS One, 10, e0127815, 10.1371/journal.pone.0127815 Robinson, 2013, Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study, Pain Med, 14, 1400, 10.1111/pme.12168 Barsky, 2002, Nonspecific medication side effects and the nocebo phenomenon, JAMA, 287, 622, 10.1001/jama.287.5.622 Hauser, 2012, Events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review, Clin J Pain, 28, 437, 10.1097/AJP.0b013e3182321ad8 Bingel, 2011, The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil, Sci Transl Med, 3, 70ra14, 10.1126/scitranslmed.3001244 Rief, 2012, The hidden effects of blinded, placebo-controlled randomized trials: an experimental investigation, Pain, 153, 2473, 10.1016/j.pain.2012.09.007 Halpern, 2015, Evaluating guideline-recommended pain medication use among patients with newly diagnosed fibromyalgia, Pain Pract Nuesch, 2013, Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis, Ann Rheum Dis, 72, 955, 10.1136/annrheumdis-2011-201249 Wolfe, 2013, Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia, Eur J Pain, 17, 581, 10.1002/j.1532-2149.2012.00234.x Collatz, 2016, A systematic review of drug therapies for chronic fatigue syndrome/myalgic encephalomyelitis, Clin Ther, 38, 1263, 10.1016/j.clinthera.2016.04.038 Fitzcharles, 2013, Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study, Pain Res Treat, 2013, 898493 Peng, 2015, Long-term evaluation of opioid treatment in fibromyalgia, Clin J Pain, 31, 7, 10.1097/AJP.0000000000000079 Pae, 2009, Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants, Expert Opin Pharmacother, 10, 1561, 10.1517/14656560902988510